Abstract
Rationale. 5-HT1B receptors are thought to be one of the receptor subtypes that mediate the inhibitory control of serotonin on food intake and satiety.
Objective. To use the selective 5-HT1B receptor agonist, CP-94,253 as a probe of 5-HT1B receptor function in feeding behaviour, and to confirm the pharmacological selectivity of CP-94,253-induced hypophagia with a range of antagonists.
Methods. Dose-response functions for CP-94,253 (0, 1.25, 2.5, 5.0 mg/kg; IP) were determined in animals consuming wet mash in a 40-min test session during which time-sampled behavioural observations were collected to evaluate satiety sequences. A meal patterning study was carried out in a separate group of rats. The 5-HT1A antagonist WAY 100,635 (0, 1.0, 3.0 mg/kg; SC), the 5-HT1B/1D antagonist GR 127,935 (0, 3 mg/kg; IP), and the 5-HT1B antagonist SB 224289 (0, 2.5, 5.0 mg/kg; IP) were used to confirm that 5-HT1B receptor subtypes were responsible for the action of CP-94,253 on feeding behaviour.
Results. CP-94,253 (2.5 mg/kg) reduced food intake and preserved the satiety sequence in animals consuming a diet of mash. GR 127,935 (3.0 mg/kg) and SB 224289 (2.5 mg/kg), but not WAY 100,635, attenuated the hypophagic effect of the 5-HT1B agonist, and returned the changes in satiety sequence to control patterns. Meal patterning analyses indicated that CP-94,253 (2.5 mg/kg) reduced food intake through a decrease in meal size and duration in the absence of any alteration in the rate of eating. A hypodipsic action of CP-94,253 was also observed (2.5 and 5.0 mg/kg).
Conclusion. These findings imply that 5-HT1B receptors regulate discrete elements of satiety. We discuss the potential role of 5-HT1B agonists for the treatment of obesity.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Lee, M.D., Kennett, G.A., Dourish, C.T. et al. 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253. Psychopharmacology 164, 49–60 (2002). https://doi.org/10.1007/s00213-002-1162-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00213-002-1162-7